Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Buprenorphine | 2 | 2023 | 193 | 1.220 |
Why?
|
| Opioid-Related Disorders | 2 | 2023 | 509 | 0.920 |
Why?
|
| Drug Prescriptions | 1 | 2023 | 168 | 0.740 |
Why?
|
| Drug Overdose | 1 | 2021 | 131 | 0.610 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 435 | 0.610 |
Why?
|
| Physicians | 1 | 2021 | 473 | 0.480 |
Why?
|
| Internship and Residency | 1 | 2021 | 805 | 0.410 |
Why?
|
| Opiate Substitution Treatment | 2 | 2023 | 207 | 0.320 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 4 | 2004 | 104 | 0.200 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2021 | 705 | 0.120 |
Why?
|
| Apoptosis | 4 | 2004 | 1080 | 0.110 |
Why?
|
| United States | 1 | 2021 | 7836 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2004 | 324 | 0.070 |
Why?
|
| Humans | 4 | 2023 | 63522 | 0.060 |
Why?
|
| Mitochondria | 3 | 2004 | 372 | 0.060 |
Why?
|
| Genes, bcl-2 | 1 | 2004 | 9 | 0.060 |
Why?
|
| Leukemia, Lymphoid | 1 | 2004 | 11 | 0.060 |
Why?
|
| Sphingosine | 1 | 2003 | 19 | 0.050 |
Why?
|
| Noscapine | 1 | 2002 | 2 | 0.050 |
Why?
|
| Melanoma, Experimental | 1 | 2002 | 44 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2003 | 281 | 0.050 |
Why?
|
| Endoplasmic Reticulum | 1 | 2003 | 174 | 0.050 |
Why?
|
| Microtubules | 1 | 2002 | 209 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2003 | 572 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 2003 | 899 | 0.040 |
Why?
|
| Calcium | 1 | 2003 | 576 | 0.040 |
Why?
|
| bcl-2-Associated X Protein | 3 | 2004 | 48 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2003 | 1009 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2002 | 662 | 0.030 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 2 | 2003 | 11 | 0.020 |
Why?
|
| Mice | 5 | 2004 | 10863 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2003 | 2166 | 0.020 |
Why?
|
| Animals | 5 | 2004 | 20715 | 0.020 |
Why?
|
| Leukemia, B-Cell | 1 | 2004 | 6 | 0.010 |
Why?
|
| Genes, myc | 1 | 2004 | 18 | 0.010 |
Why?
|
| Cytochromes c | 1 | 2004 | 28 | 0.010 |
Why?
|
| Doxycycline | 1 | 2004 | 47 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2004 | 166 | 0.010 |
Why?
|
| Attachment Sites, Microbiological | 1 | 2003 | 2 | 0.010 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2003 | 20 | 0.010 |
Why?
|
| Antigens, CD19 | 1 | 2003 | 25 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2004 | 456 | 0.010 |
Why?
|
| Integrases | 1 | 2003 | 37 | 0.010 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2003 | 7 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2003 | 31 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2003 | 195 | 0.010 |
Why?
|
| Ionomycin | 1 | 2003 | 16 | 0.010 |
Why?
|
| Histamine | 1 | 2003 | 21 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 2003 | 32 | 0.010 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2003 | 14 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 2003 | 34 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2003 | 99 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 2003 | 79 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2003 | 235 | 0.010 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2002 | 9 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2002 | 25 | 0.010 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2002 | 19 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2003 | 272 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2003 | 310 | 0.010 |
Why?
|
| Spleen | 1 | 2003 | 483 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2002 | 110 | 0.010 |
Why?
|
| Alleles | 1 | 2003 | 447 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2003 | 236 | 0.010 |
Why?
|
| Cell Survival | 1 | 2003 | 576 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2002 | 149 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2003 | 263 | 0.010 |
Why?
|
| Stem Cells | 1 | 2003 | 261 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 2003 | 159 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 490 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2002 | 369 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 452 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 1284 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2002 | 238 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 674 | 0.010 |
Why?
|
| Cytokines | 1 | 2003 | 934 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2003 | 1355 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2002 | 707 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2003 | 2113 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 1535 | 0.010 |
Why?
|
| Disease Progression | 1 | 2002 | 1170 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2002 | 3401 | 0.010 |
Why?
|
| Female | 1 | 2002 | 32935 | 0.000 |
Why?
|